Enquiry

Specification Sheet

Orlistat, ≥98%

: (−)-Tetrahydrolipstatin, N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester, Ro-18-0647

: O 0392

: C29H53NO5

: 495.73

: Orlistat, used in obesity research, is a pancreatic lipase inhibitor that acts locally in the gastrointestinal tract to inhibit lipase.

: O 0392 (OTTO) Orlistat, ≥98% Cas 96829-58-2 - used as an inhibitor of fatty acid synthase in long-term estrogen-deprived (LTED) variant cell lines.


Properties

: ≥98%

: White

: Powder or crystal or chunks

: 43-47 °C(lit.)

: 2-8 °C


Safety Information

WGK Germany 3


PackingsPrice (INR)
25 mg 15309.00
100 mg 62019.00
Custom size POR